Trial Profile
A Phase 2 Randomized, Double-blinded, Multicenter and Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Different Doses of Tolvaptan Tablet in Patients With Cirrhotic Ascites
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2018
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Liver cirrhosis
- Focus Therapeutic Use
- Sponsors Otsuka Beijing Research Institute
- 25 Nov 2018 New trial record